{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:22:59Z","timestamp":1792092179691,"version":"4.4.0"},"reference-count":40,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220211\/Z\/20\/Z"],"award-info":[{"award-number":["220211\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,4,8]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Thalassaemia, a genetic blood disorder, is a major public health burden. Most affected individuals reside in low-and-middle-income countries (LMICs). Screening programmes can reduce incidence, but in resource-constrained settings cost-effectiveness is important. This work aimed to investigate how economic evaluations of thalassaemia screening programmes have been conducted globally, to identify best practices for future evaluation suited to a LMIC context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic literature review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>The original review was undertaken between May and July 2023; an update was completed between November and December 2025. Electronic databases (MEDLINE, Embase, National Health Service Economic Evaluation Database, Health Technology Assessment Database, Cochrane Database of Systematic Reviews), economic databases (Cost-Effectiveness Analysis Registry) and grey literature (including conference proceedings) were searched. Additional validation searches were conducted in Google Scholar to identify relevant studies not indexed in the electronic databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>Studies were screened against pre-specified criteria by two independent reviewers. Eligible articles reported an economic evaluation of a thalassaemia screening programme for pregnant women or children aged 2 years or younger in any geographic setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Data extraction for each included article was performed by one author and verified by a second. Findings were interpreted within the context of LMICs, given the high prevalence and resource limitations in these settings. The quality of each article was assessed using the Critical Appraisal Skills Programme Economic Evaluation Checklist; quality assessment for each article was performed by one author and verified by a second.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 2112 publications identified from database searches, ten were ultimately included: three cost-effectiveness analyses (CEAs), six cost-benefit analyses (CBAs) and one cost-utility analysis. Study quality varied widely, with most not reporting methodological details such as discounting rates and time horizon. Additionally, no studies employed standard cost-effectiveness metrics, such as quality-adjusted life-years. Seven studies adopted simplified approaches to evaluating thalassaemia screening programmes, relying on basic cost comparisons without formal modelling. Three studies used a decision tree model structure based on the chronological sequence of steps during the screening process. Of these, two Thailand-based studies were notable, given their robust decision tree model, explicit adoption of a lifetime time horizon, application of a discounting rate in line with Thai Health Technology Assessment Guidelines, and performance of sensitivity analyses using recognised methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The frequent use of simple cost comparisons likely reflects the complexities surrounding modelling of thalassaemia screening programmes. While traditional CEAs are predominantly used in cost-effectiveness research, practical and ethical challenges associated with calculating health utility differences in this context may limit their use. However, the absence of standard metrics does not preclude a robust economic evaluation, as evidenced by the two high-quality Thailand-based studies. The methods outlined in these papers can be used as a starting point for future economic evaluations, provided the evaluation is further tailored to the local setting. If development of a model is not possible, a simpler CBA with a robust, comprehensive approach could be used. In any case, it is vital to capture the societal benefits of screening programmes; any future evaluation within this context should therefore include a broad societal perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42023445001.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-108768","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:31:07Z","timestamp":1778081467000},"page":"e108768","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Systematic review of economic evaluations in thalassaemia screening programmes globally: developing guidance for low- and middle-income (LMIC) settings"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3749-5230","authenticated-orcid":false,"given":"Katherine","family":"Massey","sequence":"first","affiliation":[{"name":"Costello Medical, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3814-0522","authenticated-orcid":false,"given":"Koukeo","family":"Phommasone","sequence":"additional","affiliation":[{"name":"Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahosot Hospital, Vientiane, Lao People\u2019s Democratic Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Mehta","sequence":"additional","affiliation":[{"name":"Costello Medical, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne Qi Yan","family":"Lee","sequence":"additional","affiliation":[{"name":"Costello Medical, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Ashley","sequence":"additional","affiliation":[{"name":"Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahosot Hospital, Vientiane, Lao People\u2019s Democratic Republic"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-9414","authenticated-orcid":false,"given":"Mayfong","family":"Mayxay","sequence":"additional","affiliation":[{"name":"Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahosot Hospital, Vientiane, Lao People\u2019s Democratic Republic"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"},{"name":"Unit for Health Evidence and Policy (UHEP), Institute of Research and Education Development, University of Health Sciences, Ministry of Health, Vientiane, Lao People\u2019s Democratic Republic"},{"name":"Saw Swee Hock School of Public Health, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7970-039X","authenticated-orcid":false,"given":"Chris","family":"Painter","sequence":"additional","affiliation":[{"name":"Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahosot Hospital, Vientiane, Lao People\u2019s Democratic Republic"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"},{"name":"Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"2026062608312154000_16.5.e108768.1","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0140-6736(22)00536-0","article-title":"Thalassaemia","volume":"399","author":"Kattamis","year":"2022","journal-title":"Lancet"},{"key":"2026062608312154000_16.5.e108768.2","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13512"},{"key":"2026062608312154000_16.5.e108768.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102619","article-title":"Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"72","author":"Tuo","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026062608312154000_16.5.e108768.4","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.894444","article-title":"Molecular spectrum, spectrum, ethnic and geographical distribution of thalassemia in the southern area of Hainan, China","volume":"10","author":"Yu","year":"2022","journal-title":"Front Pediatr"},{"key":"2026062608312154000_16.5.e108768.5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000087892","article-title":"High frequency of alpha-thalassemia in the So ethnic group of South Laos","volume":"114","author":"Sengchanh","year":"2005","journal-title":"Acta Haematol"},{"key":"2026062608312154000_16.5.e108768.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246736","article-title":"Epidemiology of thalassemia among the hill tribe population in Thailand","volume":"16","author":"Apidechkul","year":"2021","journal-title":"PLoS One"},{"key":"2026062608312154000_16.5.e108768.7","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17207354","article-title":"Prevalence of alpha(\u03b1)-thalassemia in Southeast Asia (2010-2020): a meta-analysis involving 83,674 subjects","volume":"17","author":"Goh","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2026062608312154000_16.5.e108768.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12912-024-01826-y","article-title":"A cross-sectional study: caregiver burden and related determinants of adult patients with \u03b2-thalassemia major in mainland China","volume":"23","author":"Zhang","year":"2024","journal-title":"BMC Nurs"},{"key":"2026062608312154000_16.5.e108768.9","unstructured":"Bajwa H , Basit H . Thalassaemia. 2023."},{"key":"2026062608312154000_16.5.e108768.10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/03630269.2022.2069034","article-title":"Current status of thalassemia in Lao People\u2019s Democratic Republic","volume":"46","author":"Phengsavanh","year":"2022","journal-title":"Hemoglobin"},{"key":"2026062608312154000_16.5.e108768.11","unstructured":"Laotiantimes . Laos struggles to meet blood demand amidst soaring road accident cases in 2024, 2024. Available: https:\/\/laotiantimes.com\/2024\/04\/09\/lao-red-cross-struggles-to-meet-blood-demand-amidst-rising-road-accident-cases\/#:~:text=The%20National%20Blood%20Transfusion%20Center%2C%20operated%20by%20the,recording%201403%20road%20accidents%2C%20resulting%20in%20214%20fatalities"},{"key":"2026062608312154000_16.5.e108768.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100588"},{"key":"2026062608312154000_16.5.e108768.13","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02858-4","article-title":"Economic burden of adult patients with \u03b2-thalassaemia major in mainland China","volume":"18","author":"Zhen","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2026062608312154000_16.5.e108768.14","article-title":"Thalassemia: a review of the challenges to the families and caregivers","volume":"14","author":"Yousuf","year":"2022","journal-title":"Cureus"},{"key":"2026062608312154000_16.5.e108768.15","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.4103\/jfmpc.jfmpc_90_19","article-title":"Need for a universal thalassemia screening programme in India? A public health perspective","volume":"8","author":"Thiyagarajan","year":"2019","journal-title":"J Family Med Prim Care"},{"key":"2026062608312154000_16.5.e108768.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-021-11059-2","article-title":"Feasibility of and barriers to thalassemia screening in migrant populations: a cross-sectional study of Myanmar and Cambodian migrants in Thailand","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Public Health"},{"key":"2026062608312154000_16.5.e108768.17","unstructured":"Centre for Reviews and Dissemination . Systematic Reviews: CRD\u2019s Guidance for Undertaking Reviews in Health Care. York: Centre for Reviews and Dissemination: University of York, 2008."},{"key":"2026062608312154000_16.5.e108768.18","unstructured":"PRISMA . Transparent reporting of systematic reviews and meta-analyses, 2024. Available: http:\/\/prisma-statement.org\/?AspxAutoDetectCookieSupport=1"},{"key":"2026062608312154000_16.5.e108768.19","unstructured":"Koukeo Phommasone CP , Massey K , Viswambaram A , et al . Systematic review of economic evaluations of thalassaemia screening programmes, CRD42023445001: PROSPERO. 2023. Available: https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=445001"},{"key":"2026062608312154000_16.5.e108768.20","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.722927","article-title":"An introduction to the main types of economic evaluations used for informing priority setting and resource allocation in healthcare: key features, uses, and limitations","volume":"9","author":"Turner","year":"2021","journal-title":"Front Public Health"},{"key":"2026062608312154000_16.5.e108768.21","unstructured":"Critical Appraisal Skills Programme . CASP economic evaluation checklist 2018. 2018 Available: https:\/\/casp-uk.net\/checklists-archive\/casp-econonimic-evaluation-checklist-fillable.pdf"},{"key":"2026062608312154000_16.5.e108768.22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/thalassrep12040018","article-title":"Redesigning new policy options for thalassemia prevention in in Sri Lanka","volume":"12","author":"Amarasinghe","year":"2022","journal-title":"Thalassemia Reports"},{"key":"2026062608312154000_16.5.e108768.23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/CEOR.S544493","article-title":"Cost-effectiveness analysis of different prenatal screening strategies for the prevention of severe thalassemia in Thailand","volume":"17","author":"Malasai","year":"2025","journal-title":"Clinicoecon Outcomes Res"},{"key":"2026062608312154000_16.5.e108768.24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/CEOR.S500802","article-title":"Cost-benefit analysis of genetic testing as a prenatal diagnostic tool for thalassemia: a single-center study from central Thailand","volume":"17","author":"Malasai","year":"2025","journal-title":"Clinicoecon Outcomes Res"},{"key":"2026062608312154000_16.5.e108768.25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/03630269.2016.1197840","article-title":"A program on noninvasive prenatal diagnosis of \u03b1-thalassemia in mainland China: a cost-benefit analysis","volume":"40","author":"Yang","year":"2016","journal-title":"Hemoglobin"},{"key":"2026062608312154000_16.5.e108768.26","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp11X601325"},{"key":"2026062608312154000_16.5.e108768.27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1471-0528.2000.tb13267.x","article-title":"Organisation and cost-effectiveness of antenatal haemoglobinopathy screening and follow up in a community-based programme","volume":"107","author":"Cronin","year":"2000","journal-title":"BJOG"},{"key":"2026062608312154000_16.5.e108768.28","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1035"},{"key":"2026062608312154000_16.5.e108768.29","doi-asserted-by":"publisher","DOI":"10.1136\/jms.5.3.120"},{"key":"2026062608312154000_16.5.e108768.30","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2014.012","article-title":"Prevention of \u03b2 thalassemia in northern Israel - a cost-benefit analysis","volume":"6","author":"Koren","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2026062608312154000_16.5.e108768.31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00404-006-0134-2","article-title":"A cost utility analysis of the right method for screening hemoglobin E among Thai pregnant women","volume":"274","author":"Wiwanitkit","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"2026062608312154000_16.5.e108768.32","first-page":"348","article-title":"A systematic review on thalassaemia screening and birth reduction initiatives: cost to success","volume":"79","author":"Azrin Syahida","year":"2024","journal-title":"Med J Malaysia"},{"key":"2026062608312154000_16.5.e108768.33","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20054637","article-title":"Cost-benefit analysis versus cost-effectiveness analysis from a societal perspective in healthcare","volume":"20","author":"Brent","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2026062608312154000_16.5.e108768.34","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2022.100080","article-title":"Cervical cancer screening in low- and middle-income countries: A systematic review of economic evaluation studies","volume":"77","author":"Casas","year":"2022","journal-title":"Clinics (Sao Paulo)"},{"key":"2026062608312154000_16.5.e108768.35","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-022-02017-z","article-title":"A systematic review of economic evaluations of cervical cancer screening methods","volume":"11","author":"Sefuthi","year":"2022","journal-title":"Syst Rev"},{"key":"2026062608312154000_16.5.e108768.36","first-page":"621","article-title":"A systematic review of economic evaluations of screening programmes for cardiometabolic diseases","volume":"27","author":"Hiligsmann","year":"2017","journal-title":"Eur J Public Health"},{"key":"2026062608312154000_16.5.e108768.37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011821","article-title":"Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations","volume":"6","author":"Coward","year":"2016","journal-title":"BMJ Open"},{"key":"2026062608312154000_16.5.e108768.38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jval.2021.07.009","article-title":"A pregnant pause: rethinking economic evaluation in contraception and pregnancy","volume":"25","author":"Abel","year":"2022","journal-title":"Value Health"},{"key":"2026062608312154000_16.5.e108768.39","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X15583845"},{"key":"2026062608312154000_16.5.e108768.40","first-page":"1","article-title":"Carrier screening programs for cystic fibrosis, fragile x syndrome, hemoglobinopathies and thalassemia, and spinal muscular atrophy: a health technology assessment","volume":"23","author":"Health","year":"2023","journal-title":"Ont Health Technol Assess Ser"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-108768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:39:40Z","timestamp":1782488380000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-108768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,6]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjopen-2025-108768"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-108768","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}